THE DYNAMICS OF MATRIX PROTEINS EXCRETION WITH URINE UNDER PYELONEPHRITIS IN CHILDREN

Yu. A Leontiyeva , S. S Paunova , A. G Kutcherenko , I. E Smirnov , L. A Revenkova , E. A Temerina , O. V Anokhina

Russian Medicine ›› 2012, Vol. 18 ›› Issue (6) : 24 -26.

PDF
Russian Medicine ›› 2012, Vol. 18 ›› Issue (6) : 24 -26. DOI: 10.17816/rmj38068
Articles
research-article

THE DYNAMICS OF MATRIX PROTEINS EXCRETION WITH URINE UNDER PYELONEPHRITIS IN CHILDREN

Author information +
History +
PDF

Abstract

In children, infectious inflammatory diseases of organs of urinary system, pyelonephritis included, can result in renal tissue hardening as a result of excessive accumulation of components of extracellular matrix in interstitial tissue due to imbalance in the synthesis/proteins degradation system of extracellular matrix. The degradation of proteins occurs under impact of proteinases, in particular matrix metalloproteinases named as biological markers of fibrosis. The study covered the evaluation of content of metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinases 1 in urine of 135 children with pyelonephritis. The established disorders of balance between pro-inflammatory and antiinflammatory, pro-sclerotic compounds can testify the atypical course of inflammation with subsequent formation of sclerosis focuses. This is needed for assigning the treatment tactics and following-up of patients with pyelonephritis.

Keywords

children / pyelonephritis / protein degradation / treatment tactic

Cite this article

Download citation ▾
Yu. A Leontiyeva, S. S Paunova, A. G Kutcherenko, I. E Smirnov, L. A Revenkova, E. A Temerina, O. V Anokhina. THE DYNAMICS OF MATRIX PROTEINS EXCRETION WITH URINE UNDER PYELONEPHRITIS IN CHILDREN. Russian Medicine, 2012, 18(6): 24-26 DOI:10.17816/rmj38068

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Ли О.А., Бобкова И.Н., Козловская Л.В. // Клин. нефрол. - 2009. № 1. - С. 50-54.

[2]

Bengatta S., Arnould C., Letavernier E. et al. // J. Am. Soc. Nephrol. - 2009. - Vol. 20, N 4. - P. 787-797.

[3]

Carome M.A., Striker L.J., Peten E.P. et al. // Am. J. Physiol. Renal Fluid Electrolyte Physiol. - 1993. - Vol. 264. - P. 923.

[4]

Catania J.M., Chen G., Parrish A.R. // Am. J. Physiol. Renal Physiol. - 2007. - N 292. - P. 905.

[5]

Cheng S., Pollock A., Mahimkar R. et al. //FASEB J. - 2006. - Vol. 20. - P. 1898-1900.

[6]

Chromek M., Tullus K., Hertting O. et al. // Pediatr. Res. - 2003. -Vol. 53. - P. 698-705.

[7]

Duymelinck C., Deng J.T., Dauwe S.E. et al. // Kidney Int. - 1998. -Vol. 54. - P. 804.

[8]

El-Nahas A.M. // Kidney Int. - 2003. - Vol. 64. - P. 1553.

[9]

Fukui N., McAlinden A., Zhu Y. et al. // J. Biol. Chem. - 2002. - Vol. 277, N 3. - P. 2193-2201.

[10]

Jain S., Bicknell G.R., Nicholson M.L. // Br. J. Surg. - 2000. - Vol. 87. - P. 1188.

[11]

Leib S.L., Leppert D., Clements J., Tauber M.G. // Infect. Immun. - 2000. - Vol. 68. - P. 615-620.

[12]

Lenz O., Elliot S.J., Stetler-Stevenson W.G. : Matrix metalloproteinases in renal development and disease. // J. Am. Soc. Nephrol. - 2000. -Vol. 11. - P. 574-581.

[13]

Nagase H., Woessner J.P. // J. Biol. Chem. - 1999. - Vol. 274, N 31. - P. 21491-21494.

[14]

Piedagnel R., Murphy G., Ronco P.M. et al. // J. Biol. Chem. - 1999. -Vol. 274, N31. - р. 1614.

[15]

Raffetto J., Khalil R. // Biochem. Pharmacol. - 2008. - Vol. 75, N 2. - P. 346-359.

[16]

Tenderenda E., Zoch-Zwierz W., Wasilewska A., et al. // Pol. Merkur. Lek. - 2009. - Vol. 157, N 27. - P. 10-13.

[17]

Zaoui P., Cantin J.F., Alimardani-Bessette M., et al. // Diabet. Metab. - 2000. - Vol. 26 (suppl. 4). - P. 25-29.

[18]

Zeisberg M., Maeshima Y., Mosterman B., Kalluri R. // Am. J. Pathol. - 2002. Vol. 160, N 6. - P. 2001-2008.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

130

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/